课题基金 / 基金详情

MFRPS Maintenance NYSAGM

MFRPS Maintenance NYSAGM
MFRPS 维护 NYSAGM
批准号:
10828201
负责人:
Dan McCarthy
金额:
$30.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-15 至 2026-06-30
关键词:

项目摘要

项目成果

Dan McCarthy的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要: 纽约州农业和市场部拥有广泛的食品安全和 检查程序,包括对制造食品设施的管辖权。该司 食品安全和检验已被纳入FDA的制成品监管 计划标准自2008年以来,目前正在全面实施和完全符合 2019年MFRPS标准。 该标准为国家制造食品项目提供了质量管理 这是一个国家统一的食品安全体系的基础。林业发展局供资, FSI将使我们能够保持全面实施2022年标准,继续 我们的检查人员的能力,支持培训,提供必要的人力资源, 维护标准,维护审计、数据采集和报告系统,并进一步 信息共享有了额外的特别项目资金,国家希望扩大 我们目前的独立课程交付培训从FD 190,包括FD 202,FD 249和 FD 254通过与FDA的Patricia Alcock和FDA/ORA/OTED团队合作。
英文摘要
Project Abstract: The New York State Department of Agriculture and Markets has an extensive food safety and inspection program which includes jurisdiction over manufactured foods facilities. The Division of Food Safety and Inspection has been enrolled in FDA's Manufactured Foods Regulatory Program Standards since 2008 and is currently in full implementation and full conformance of 2019 MFRPS standards. The Standards provide State manufactured food programs with a quality management framework, and a foundation for a nationally integrated food safety system. Funding by FDA to FSI will enable the maintenance of our full implementation to the 2022 Standards, continue the capabilities of our inspection staff, support training, provide necessary staff resources to maintain the Standards, maintain systems for auditing, data capture, and reporting and further information sharing. With the additional special project funding, the State would like to expand our current independent course delivery trainings from FD190, to include FD202, FD249 and FD254 by working with FDA’s Patricia Alcock and the FDA/ORA/OTED team.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Conformance with the Manufactured Food Regulatory Program Standards (MFRPS) Flexible Funding Model
Conformance with the Manufactured Food Regulatory Program Standards (MFRPS) Flexible Funding Model
FSMA Human Foods Preventive Controls Implementation Expansion Supplement to RFA-FD-18-001 (U18 Clinical Trials Not Allowed)
海外基金